Current role of dexmedetomidine in clinical anesthesia and intensive care
- PMID: 25885374
- PMCID: PMC4173414
- DOI: 10.4103/0259-1162.94750
Current role of dexmedetomidine in clinical anesthesia and intensive care
Abstract
Dexmedetomidine is a new generation highly selective α2-adrenergic receptor (α2-AR) agonist that is associated with sedative and analgesic sparing effects, reduced delirium and agitation, perioperative sympatholysis, cardiovascular stabilizing effects, and preservation of respiratory function. The aim of this review is to present the most recent topics regarding the advantages in using dexmedetomidine in clinical anesthesia and intensive care, while discussing the controversial issues of its harmful effects.
Keywords: Dexmedetomidine; intensive care unit sedation; α2-adrenergic receptor agonist.
Conflict of interest statement
Figures
References
-
- Kemp KM, Henderlight L, Neville M. Precedex: Is it the future of cooperative sedation? Nursing. 2008;38(Suppl Critical):7–8. - PubMed
-
- Takrouri MS, Seraj MA, Channa AB, el-Dawlatly AA, Thallage A, Riad W, et al. Dexmedetomidine in intensive care unit: A study of hemodynamic changes. Middle East J Anesthesiol. 2002;16:587–95. - PubMed
-
- Takrouri MS. New concepts in intensive care: Dexmedetomidine and immunonutrition. Middle East J Anesthesiol. 2002;16:567–72. - PubMed
-
- Dexmedetomidine. [Last accessed on 2011 March 18]. Available from: http://en.wikipedia.org/wiki/Dexmedetomidine .
-
- Afsani N. Clinical application of dexmedetomidine. S Afr J Anaesthesiol Analg. 2010;16:50–6.
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials